It is generally associated with the presence of tumor-infiltrating lymphocytes and poor prognostic features, such as high grade and aggressive molecular subtypes (triple-negative, basal, and human epidermal growth receptor 2- (HER2-) enriched). The gene discussed is ERBB2; the disease is neoplasm.